Clinical Trial Update: Evaluate the Efficacy and Safety of GZR33 Injection in Patients With Type 2 Diabetes [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the efficacy and safety of GZR33 Injection for type 2 diabetes; the study is currently NOT_YET_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• GZR33 Injection

Snippet

Sponsor: Gan & Lee Pharmaceuticals. | Conditions: Type 2 Diabetes (T2DM) | Phase 3 | Status: NOT_YET_RECRUITING